MVRBF
Price:
$0.82
Market Cap:
$402.33M
Medivir AB (publ) researches, develops, and sells pharmaceuticals primarily for the treatment of oncology in Sweden and internationally. The company markets Xerclear for the treatment of labial herpes under the Zoviduo name. It also develops Remetinostat for treating MF cutaneous T-cell lymphoma, as well as basal cell carcinoma. In addition, the company develops MIV-818 for the treatment of liver cancer; MIV-711 to treat osteoarthritis; and Birinapant and IGM-8444 for the treatment of solid tumors. It has a research collaboration with the Drug Discovery and Development Platform at SciLifeLab for the discovery of antivirals for SARS CoV-2; and a licensing agreement with the Tango Therapeutics...[Read more]
Industry
Biotechnology
IPO Date
2010-06-22
Stock Exchange
OTC
Ticker
MVRBF
According to Medivir AB (publ)’s latest financial reports and current stock price. The company's current PE Ratio is -6.31. This represents a change of 1.02% compared to the average of -6.24 of the last 4 quarters.
The mean historical PE Ratio of Medivir AB (publ) over the last ten years is -13.43. The current -6.31 PE Ratio has changed 4.60% with respect to the historical average. Over the past ten years (40 quarters), MVRBF's PE Ratio was at its highest in in the December 2013 quarter at 41.97. The PE Ratio was at its lowest in in the September 2013 quarter at -93.01.
Average
-13.43
Median
-3.28
Minimum
-150.78
Maximum
30.86
Discovering the peaks and valleys of Medivir AB (publ) PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.14%
Maximum Annual PE Ratio = 30.86
Minimum Annual Increase = -131.55%
Minimum Annual PE Ratio = -150.78
| Year | PE Ratio | Change |
|---|---|---|
| 2022 | -6.18 | -33.74% |
| 2021 | -9.33 | 90.04% |
| 2020 | -4.91 | 65.28% |
| 2019 | -2.97 | 43.29% |
| 2018 | -2.07 | -42.18% |
| 2017 | -3.59 | -131.55% |
| 2016 | 11.37 | -63.16% |
| 2015 | 30.86 | 834.51% |
| 2014 | 3.30 | -102.19% |
| 2013 | -150.78 | 1.14% |
The current PE Ratio of Medivir AB (publ) (MVRBF) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
-6.81
5-year avg
-5.09
10-year avg
-13.43
Medivir AB (publ)’s PE Ratio is greater than Abliva AB (publ) (-9.56), less than Relief Therapeutics Holding AG (-2.06), less than Oncopeptides AB (publ) (-4.54), greater than Biostage, Inc. (-9.60), less than Small Pharma Inc. (-2.19), less than Mindset Pharma Inc. (-4.01), greater than Alpha Cognition Inc. (-8.68), greater than Herantis Pharma Oyj (-9.37), less than Karolinska Development AB (publ) (-0.71), less than IntelGenx Technologies Corp. (-2.99),
| Company | PE Ratio | Market cap |
|---|---|---|
| -9.56 | $45.13M | |
| -2.06 | $44.94M | |
| -4.54 | $55.98M | |
| -9.60 | $57.82M | |
| -2.19 | $37.51M | |
| -4.01 | $54.51M | |
| -8.68 | $35.66M | |
| -9.37 | $59.47M | |
| -0.71 | $68.85M | |
| -2.99 | $29.69M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Medivir AB (publ) using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Medivir AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Medivir AB (publ)'s PE Ratio?
How is the PE Ratio calculated for Medivir AB (publ) (MVRBF)?
What is the highest PE Ratio for Medivir AB (publ) (MVRBF)?
What is the 3-year average PE Ratio for Medivir AB (publ) (MVRBF)?
What is the 5-year average PE Ratio for Medivir AB (publ) (MVRBF)?
How does the current PE Ratio for Medivir AB (publ) (MVRBF) compare to its historical average?